The general line of questions from investors was in relation to the sales pipeline and timing of sales coming to fruition.
The discussion and responses led by Chuck and Martin were focused on scaling the manufacturing capability through licensed partners to meet sales demand.
It was very interesting to observe this distinction time and time again.
Whilst investors still require some convincing (as reflected in the SP), the company is miles ahead in their thinking & planning, convinced they’ve nailed the product and sales are a given.
Sustained Long term success is dependant on quality manufacturing through numerous licensed partners.
The company is right to invest their time and effort here as priority number 1.
Keep accumulating all, this is an amazing opportunity!! I still can’t believe that the market has somehow yet to catch on. Won’t be this cheap for much longer.
A Bill Gates backed Luxwall ‘needs us more than we need them’ according to Chuck. Says it all.
The general line of questions from investors was in relation to...
Add CPV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.020(3.45%) |
Mkt cap ! $145.5M | |||
| Open | High | Low | Value | Volume |
| 58.0¢ | 60.0¢ | 56.5¢ | $356.5K | 610.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 105559 | 7 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| CPV (ASX) Chart |